JP4902939B2 - 次亜塩素酸組成物及びその使用 - Google Patents
次亜塩素酸組成物及びその使用 Download PDFInfo
- Publication number
- JP4902939B2 JP4902939B2 JP2003532072A JP2003532072A JP4902939B2 JP 4902939 B2 JP4902939 B2 JP 4902939B2 JP 2003532072 A JP2003532072 A JP 2003532072A JP 2003532072 A JP2003532072 A JP 2003532072A JP 4902939 B2 JP4902939 B2 JP 4902939B2
- Authority
- JP
- Japan
- Prior art keywords
- hypochlorous acid
- composition according
- acid composition
- disinfection
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
- A61L2/186—Peroxide solutions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/358—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/17—Combination with washing or cleaning means
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/76—Treatment of water, waste water, or sewage by oxidation with halogens or compounds of halogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
Description
本願特許明細書に係る発明は次亜塩素酸組成物及びその様々な使用、特に医薬の分野、例えば感染制御のための予防及び治療処置に関するものである。
1915年以降、第一次世界大戦の結果として、200以上の細菌性活性組成物、中でも次亜塩素酸組成物が研究されてきた。それは好中球によって生成される酸化剤として最初に発見されたものであり、海水から得られた。
本発明の次亜塩素酸及びその種々の使用は従来技術を越えて以下の利点を有する:
・本次亜塩素酸組成物は毒性を有さず、皮膚に刺激を与えない。
・本組成物は十分に生体分解性である。
・より広い範囲の消毒を数秒で行う。
・メルカプタン、メタン及び硫化水素ガスを攻撃するので脱臭剤として有機粒子を破壊する。
・24時間以内の静菌力を有する。
・組成物を得る場合の工程がその希釈物が豊富に得られるため経済的である。
生物内において反応を起こさず、抗菌剤及び薬物に耐性を有する微生物に高い効果がある物質の発見への関心から、主に腹腔及び組織を洗浄するために使用される物質である通常の食塩水と比較して、細菌感染によって生じる疾病率及び死亡率を最小限にすることを特徴とする物質である次亜塩素酸の研究に至った。
化学式 HOCl
外見 結晶構造
臭い 塩素特有の臭い
塩素(g/l) 最大16−18
pH 5−6
次亜塩素酸組成物の密度(g/ml) 0.9−1.05
ORP(酸化還元電位) 1250−1450mv
化学組成は:
次亜塩素酸 6.5−7.3wt%
塩酸 27.6−28.5wt%
塩化ナトリウム 13.6−14.2wt%
次亜塩素酸ナトリウム 34.8−35.4wt%
溶液中の塩素 7−6.5wt%
溶存酸素 10.5−8.1wt%
溶液の安定性は、塩素濃度、溶液のpH、溶液温度、露光量に依存する。
本特許発明の目的である次亜塩素酸組成物は、医薬品の分野において、以下の主要な用途を有する。
2.予防:a)清潔または汚染された外科創傷の洗浄、b)初期の虫垂炎及び胆嚢炎の腹腔の局所洗浄、c)表面及び部位の消毒。
3.非医薬品:1.食物の消毒及び殺菌、2.水処理及び給水システム。
腹部手術
5000ppmの次亜塩素酸組成物の300回の試用は局所または全身の外科創傷及び腹腔の組織的洗浄に効果があった。
2090以上の患者を扱った。5%の次亜塩素酸組成物を動脈/静脈発生の潰瘍病変、外科創傷、予防的及び治療的切断上に用いた。局所使用においてのみ、感染領域は液体で湿気を保つことが推奨される。
優/良:治療前の、感染外傷、外傷性壊死及び虚血からの難治性病変を含む潰瘍の全治癒が38%。
有望:肉芽組織の出現及び潰瘍部分の減少が12%だが、全撤廃または治癒はしていない。
Claims (9)
- 以下の化学組成を有することを特徴とする次亜塩素酸組成物。
次亜塩素酸 6.5−7.3wt%
塩酸 27.6−28.5wt%
塩化ナトリウム 13.6−14.2wt%
次亜塩素酸ナトリウム 34.8−35.4wt%
溶液中の塩素 7−6.5wt%
溶存酸素 10.5−8.1wt% - 以下の物理的性質を有することを特徴とする、請求項1に記載の組成物を含む次亜塩素酸溶液。
pH 5−6
次亜塩素酸組成物の密度(g/ml) 0.9−1.05
ORP(酸化還元電位) 1250−1450mv - 塩素量が16g/l〜18g/lであることを特徴とする、請求項1に記載の次亜塩素酸組成物。
- 前記組成物が以下の治療のためのヒトの医療用用途を有する、請求項1に記載の次亜塩素酸組成物。
a)感染組織、膿瘍、蜂巣炎等の肉芽形成及び消毒用
b)下肢上の潰瘍
c)腹膜炎及び蓄膿症のような曝露表面及び開口部の感染空洞
d)感染性洞炎及び鼻炎
e)敗血症関節炎の関節内注射による治療 - 前記組成物が以下のヒトの医療用用途を有する、請求項1に記載の次亜塩素酸組成物。
a)清潔または汚染された外科創傷の洗浄
b)初期の虫垂炎及び胆嚢炎の腹腔の局所洗浄
c)表面及び部位の消毒 - 前記組成物が以下の用途を有することを特徴とする、請求項1に記載の次亜塩素酸組成物。
a.食物の消毒及び殺菌
b.水処理及び給水システム - 前記組成物が以下の獣医学診療における用途を有することを特徴とする、請求項1に記載の次亜塩素酸組成物。
a)清潔または汚染された外科創傷の洗浄
b)表面及び部位の消毒 - 前記組成物が以下の獣医学治療における用途を有することを特徴とする、請求項1に記載の次亜塩素酸組成物。
a)感染組織、膿瘍等の肉芽形成及び消毒用
b)あらゆる種類の潰瘍形成 - 前記組成物が花栽培において以下の用途を有することを特徴とする、請求項1に記載の次亜塩素酸組成物。
a)収穫物の消毒
b)フサリウム属菌及びシガトガ病原菌(sigatoka negra)の除去
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2001/002085 WO2003028741A1 (es) | 2001-10-01 | 2001-10-01 | Composicion de acido hipocloroso y sus aplicaciones |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005507395A JP2005507395A (ja) | 2005-03-17 |
JP2005507395A5 JP2005507395A5 (ja) | 2012-01-05 |
JP4902939B2 true JP4902939B2 (ja) | 2012-03-21 |
Family
ID=11004205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003532072A Expired - Fee Related JP4902939B2 (ja) | 2001-10-01 | 2001-10-01 | 次亜塩素酸組成物及びその使用 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7323118B2 (ja) |
EP (1) | EP1432427B1 (ja) |
JP (1) | JP4902939B2 (ja) |
CN (1) | CN1272020C (ja) |
BR (1) | BRPI0117143B1 (ja) |
CA (1) | CA2461921C (ja) |
DE (1) | DE60111430T2 (ja) |
ES (1) | ES2243569T3 (ja) |
MX (1) | MXPA03007514A (ja) |
WO (1) | WO2003028741A1 (ja) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0609711B8 (pt) | 2005-03-23 | 2021-05-25 | Oculus Innovative Sciences Inc | uso de uma solução aquosa com potencial redutivo oxidativo (orp) |
US20090221989A1 (en) * | 2005-09-21 | 2009-09-03 | Novabay Pharmaceuticals Inc | System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid composition |
RU2472713C2 (ru) * | 2005-10-28 | 2013-01-20 | Акуатек С.Р.Л. | Новый высокостабильный водный раствор, электрод с нанопокрытием для приготовления раствора и способ изготовления этого электрода |
US8147444B2 (en) | 2006-01-20 | 2012-04-03 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
JP2008195612A (ja) * | 2006-09-21 | 2008-08-28 | Gouda:Kk | 次亜塩素酸による病気の予防及び治療法。 |
US8877257B2 (en) * | 2007-01-16 | 2014-11-04 | Puricore, Inc. | Methods and compositions for treating conditions associated with infection and/or inflammation |
US9999635B2 (en) | 2007-01-16 | 2018-06-19 | Realm Therapeutics, Inc. | Methods and compositions for treating inflammatory disorders |
US8784900B2 (en) * | 2007-03-13 | 2014-07-22 | Oculus Innovative Sciences, Inc. | Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same |
PT2162140E (pt) | 2007-04-25 | 2013-08-27 | Apr Nanotechnologies S A | Água electrolítica altamente estável com largura reduzida de meia linha da rmn |
US8945630B2 (en) | 2008-04-11 | 2015-02-03 | Aquilabs S.A. | Method of producing and applications of composition of hypochlorous acid |
PL2376093T3 (pl) * | 2008-12-22 | 2021-01-25 | Sonoma Pharmaceuticals, Inc. | Leczenie lub profilaktyka zakażeń związanych z biofilmami z użyciem wody zawierającej wolny dostępny chlor |
WO2010148004A1 (en) | 2009-06-15 | 2010-12-23 | Oculus Innovative Sciences, Inc. | Solution containing hypochlorous acid and methods of using same |
ES2549913T3 (es) * | 2009-06-17 | 2015-11-03 | Apr Nanotechnologies S.A. | Métodos de tratamiento de trastornos oculares externos usando agua ácida de alto ORP y composiciones de la misma |
US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
US8771753B2 (en) | 2011-09-16 | 2014-07-08 | Zurex Pharmagra, Llc | Systems and methods for generating germicidal compositions |
CN104351911A (zh) * | 2014-06-12 | 2015-02-18 | 赵壮志 | 一种食品保鲜灭菌消毒方法 |
WO2017189792A1 (en) * | 2016-04-27 | 2017-11-02 | Biiosmart Technologies Llc | Use of hypochlorous acid as a topical antimicrobial |
SG11201912534SA (en) | 2017-06-28 | 2020-01-30 | Collidion Inc | Compositions, methods and uses for cleaning, disinfecting and/or sterilizing |
KR20200123421A (ko) | 2018-01-14 | 2020-10-29 | 콜리디온, 인코포레이티드 | 세척, 소독, 멸균 및/또는 치료를 위한 조성물, 키트, 방법 및 용도 |
RU2697667C1 (ru) * | 2018-10-12 | 2019-08-16 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) | Способ дезинфекции объектов ветеринарного надзора |
CA3143270A1 (en) | 2019-06-14 | 2020-12-17 | Collidion, Inc. | Compositions, kits, methods and uses for preventing microbial growth |
CN110801530A (zh) * | 2019-11-27 | 2020-02-18 | 苏州汇涵医用科技发展有限公司 | 无菌液体敷料及其制备方法 |
WO2021113384A1 (en) * | 2019-12-02 | 2021-06-10 | Preservation Tech LLC | Systems and methods for disinfecting meat products |
IL295553A (en) * | 2020-02-14 | 2022-10-01 | Collidion Inc | Compounds, kits, methods and uses for cleaning, disinfection, sterilization and/or treatment |
CN115702949A (zh) * | 2021-08-05 | 2023-02-17 | 卫盾生物科技(广州)有限公司 | 一种阻隔和灭活sars-cov-2病毒的伤口无菌液体敷料 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3553242B2 (ja) * | 1995-11-02 | 2004-08-11 | 日機装株式会社 | 血液透析装置殺菌消毒用弱酸性電解酸性水生成装置 |
JP2001046548A (ja) * | 1999-08-10 | 2001-02-20 | Canon Inc | ハロゲン化脂肪族炭化水素化合物の分解方法及びそれに用いる装置 |
GB2355190B (en) * | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
JP3825958B2 (ja) * | 1999-12-22 | 2006-09-27 | キヤノン株式会社 | 塩素含有気体発生装置及び該塩素含有気体発生装置を用いた汚染気体分解装置 |
US6426066B1 (en) * | 2000-01-12 | 2002-07-30 | California Pacific Labs, Inc. | Use of physiologically balanced, ionized, acidic solution in wound healing |
US6599431B2 (en) * | 2000-06-16 | 2003-07-29 | Canon Kabushiki Kaisha | Purifying apparatus for contaminated water and ground water and method thereof |
-
2001
- 2001-10-01 ES ES01980814T patent/ES2243569T3/es not_active Expired - Lifetime
- 2001-10-01 BR BRPI0117143-7A patent/BRPI0117143B1/pt not_active IP Right Cessation
- 2001-10-01 CN CNB018223729A patent/CN1272020C/zh not_active Expired - Fee Related
- 2001-10-01 MX MXPA03007514A patent/MXPA03007514A/es active IP Right Grant
- 2001-10-01 EP EP01980814A patent/EP1432427B1/en not_active Expired - Lifetime
- 2001-10-01 CA CA002461921A patent/CA2461921C/en not_active Expired - Lifetime
- 2001-10-01 US US10/467,121 patent/US7323118B2/en not_active Expired - Fee Related
- 2001-10-01 DE DE60111430T patent/DE60111430T2/de not_active Expired - Lifetime
- 2001-10-01 JP JP2003532072A patent/JP4902939B2/ja not_active Expired - Fee Related
- 2001-10-01 WO PCT/IB2001/002085 patent/WO2003028741A1/es active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
CN1487835A (zh) | 2004-04-07 |
CA2461921A1 (en) | 2003-04-10 |
US7323118B2 (en) | 2008-01-29 |
BRPI0117143B1 (pt) | 2015-07-14 |
WO2003028741A1 (es) | 2003-04-10 |
EP1432427A1 (en) | 2004-06-30 |
DE60111430T2 (de) | 2006-05-11 |
CN1272020C (zh) | 2006-08-30 |
JP2005507395A (ja) | 2005-03-17 |
ES2243569T3 (es) | 2005-12-01 |
MXPA03007514A (es) | 2003-12-04 |
EP1432427B1 (en) | 2005-06-08 |
CA2461921C (en) | 2008-07-29 |
DE60111430D1 (de) | 2005-07-14 |
BR0117143A (pt) | 2004-10-26 |
US20040062818A1 (en) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4902939B2 (ja) | 次亜塩素酸組成物及びその使用 | |
US8945630B2 (en) | Method of producing and applications of composition of hypochlorous acid | |
US10576152B2 (en) | Stabilized hypohalous acid solutions | |
JP2014515737A (ja) | HOClの安定な組成物、その製造方法、およびその使用 | |
EP1214081A2 (en) | Superoxidized water based on hypochlorous acid for the treatment of wounds | |
US20140328945A1 (en) | METHOD FOR STABILIZING AN ELECTROCHEMICALLY GENERATED SANITIZING SOLUTION HAVING A PREDETERMINED LEVEL OF FREE AVAILABLE CHLORINE AND pH | |
US11452778B2 (en) | Stabilized hypohalous acid solutions | |
Robins et al. | Comparison of the myeloperoxidase (MPO) enzyme system to antibiotics for irrigation of implant material | |
MXPA05008386A (es) | Solucion electrolizada superoxidada con ph. neutro. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080513 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080813 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080820 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080912 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081118 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100622 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100622 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111011 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111014 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20111110 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120104 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4902939 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150113 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |